Vaccine Equity FAQs
Read MorePartner With Us
Read MoreBivalent Doses
Source: FDA.gov On April 18, 2023, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered […]
Read MoreMedical Providers
Medical providers who wish to vaccinate individuals must enroll in the state’s immunization system through a separate process. Information and instructions can be found on the Medical Provider page here.
Read MorePharmacies
Pharmacies Vaccinating Glasgow Pharmacy Pfizer Moderna *Appointments required (except for pediatric, walk-ins between 12:00 p.m. to 6:00 p.m. Monday to Friday; appointments still preferred) 302-838-8700
Read MoreVaccination Events
Make a Vaccination Event Request (Delawareans 16+ only) Invitations to schedule an appointment are not issued based on the order you signed up, they are based on age and other health risk factors. Click below to request an appointment for an upcoming COVID-19 vaccination event.
Read MoreWhere can I get my vaccine?
Walk-In Vaccination Appointments at Division of Public Health Clinics Homebound Vaccination Program If you are unable to leave your home because of disability, age or severe illness, DHSS’ Homebound Vaccination Program can bring the vaccine to Delawareans who qualify. Vaccinations will be delivered through a partnership with Delaware independent pharmacies. Please […]
Read MoreVaccination Playbook
Read More
Vaccine Safety and Monitoring
FDA Approves Pfizer for Ages 16+ The U.S. Food & Drug Administration (FDA) has given full approval for the COVID-19 Pfizer-BioNTech vaccine for individuals 16+. Previously, the vaccine was being distributed only under an Emergency Use Authorization (EUA). There was not enough data to extend full approval to cover persons 12-15 at this time, but […]
Read More
